Pharma Nord, Inc.

4 Argonne Avenue
Hamilton,  NJ  08620

United States
  • Booth: 15095

Pharma Nord ApS - a Scandinavian manufacturer with focus on medicine for cardiovascular diseases based on a Coenzyme Q10 API. Pharma Nord actively supports science in its efforts to find new treatments or adjunctive therapies with a low risk factor. More than 100 scientific studies have been carried out using Pharma Nord’s two CoQ10 preparations, Myoqinon and Bio-Quinone. Myoqinon is registered as a medical drug in several EU countries. The products have been used in numerous studies, including in the groundbreaking Q-Symbio study that is published in the Journal of the American College of Cardiology. The products have been assigned an IND.